Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide in REM Obstructive Sleep Apnea
NCT05589792Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide in obstructive sleep apnea (OSA), sponsored by Brigham and Women's Hospital. Started Jan 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05589792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05589792.